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Abstract
Damage to DNA is intrinsic to life, as the cell continuosly suffers from numerous 
exogenous agents, including radiation and chemicals, and from endogenous sources, such as 
free radicals generated during essential metabolic processes. The broad spectrum of DNA 
lesions induced by these agents includes damage to nucleotide bases, DNA protein cross-
links and DNA single- and double-strand breaks (DBSs). Because of their high cytotoxicity 
(unrepaired  or  misrepaired  DNA  DSBs  can  kill  a  cell)  and  their  ability  to  induce 
chromosomal  aberrations  (that  may  ultimately  lead  to  carcinogenesis)  cell  survival  and 
mantenaince of genome integrity are critically dependent on efficient repair of DNA DSBs. 
When the burden of genomic insult is too large to be effectively repaired, cells are able to 
initiate apoptosis (programmed cell death). On the basis of these considerations, the aim of 
this thesis has been to investigate the role of apoptosis in the final outcome of DNA damage.
Since G0 lymphocytes are the most common tissue used in biodosimetry studies, and 
the amount of chromosomal damage detected depends on the time between exposure and 
sampling,  it  was  of  interest  to  investigate  the  relationship  between  the  frequencies  of 
radiation  induced  chromosomal  aberrations  and  the  extent  of  apoptosis  in  G0 human 
lymphocytes  (Paper  I).  In  human  lymphocytes  irradiated  in  G0 without  subsequent 
stimulation to proliferate, a p53-dependent apoptotic pathway preferentially eliminates cells 
bearing unstable aberrations.
Studies in Paper II demonstrated that in human lymphocytes the type of chromosome 
damage influences the induction of programmed cell death and provided direct evidence that 
cells bearing dicentric chromosomes are eliminated by apoptosis.
The  lymphocytes  undergo  apoptosis  during  storage,  and  this  loss  of  viability  is 
accelerated by increasing both temperature and storage time, was demonstrated in Paper III. 
Studies on the effects of storage conditions of whole blood on the viability and proliferation 
of  lymphocytes  revealed  optimal  the  storage  at  4°C  for  96  h  in  the  presence  of 
phytohaemagglutinin.
The influence of genetic background on the induction of apoptosis in cells of different 
origin, treated with a potential anticancer drug “STDS2323”, was studied in Paper IV.
In conclusion, this thesis suggests that apoptosis has an important role in the final 
outcome of DNA damage. The thesis further suggests that these results may have relevance 
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for biodosimetrical and molecular epidemiological studies and in evaluations of the efficacy 
of radio- and chemotherapy.
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INTRODUCTION
The  maintenance  and  replication  of  genetic  information  in  DNA  are  of  primary 
importance for living organisms. Damage to DNA is intrinsic to life, as the cell continuously 
suffers  from  numerous  exogenous  agents,  including  radiation  and  chemicals,  and  from 
endogenous sources,  such as free radicals  generated  during essential  metabolic  processes 
(Friedberg et al. 1995).
Radiation 
Radiation  can  be  divided  into  two  main  categories:  electromagnetic  and  particle 
radiation.  Electromagnetic  radiation may  be  defined  as  waves  and  or/photons.  The 
electromagnetic spectrum is the range of wavelengths and frequencies that electromagnetic 
radiation  can  assume.  This  is  a  very  broad  range,  and  these  waves  exhibit  a  variety  of 
properties  associated  with  wavelength  and  frequency.  It  includes,  in  order  of  increasing 
frequency,  radio waves, microwaves, infrared waves, visible light, ultraviolet rays, X- rays, 
and gamma rays. X-rays are divided into two categories: soft and hard X-rays. Soft X-rays 
have longer wavelengths and are closer to the ultraviolet band of the spectrum. Hard X-rays 
are closer to the gamma ray band of the spectrum and have much shorter wavelengths. X-
rays  are produced when material  objects hit high-velocity electrons.  Gamma rays are the 
shortest-wavelength,  highest-frequency  type  of  electromagnetic  radiation.  They  are 
essentially  identical  to  X-rays  in  their  effect,  but  are  the  most  penetrating  of  all 
electromagnetic radiation being produced by excited nuclei instead of inner electrons. X-rays 
are  generated  by  instruments  (X-rays  machines),  while  gamma  rays  are  produced  by 
radioactive decay.
Particle radiation can be emitted from unstable atomic nuclei (radioactive decay) in 
the  form of  positively  charged  alpha  particles  (helium nuclei),  positively  and negatively 
charged  beta  particles  (electrons  and  positrons)  and  uncharged  neutrons.  They  can  also 
artificially be produced, for example by cyclotrons.
Ionizing and non-ionizing radiation
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When  the  energy  of  radiation  is  high  enough  it  will  produce  ionizations  and 
excitations  in  the  target.  Radiation  that  causes  ionizations  (ejecting  one  or  more  orbital 
electrons) is called “ionizing radiation”, and corresponds to radiation with energy higher 
than a few electron volts (eV) to 24.5 eV (for helium), and is related to the ionizing potential 
of  the  atom  (Podgorsak  2003).  This  energy  is  the  minimum  energy  to  ionize  an  atom 
(removing an electron from its atoms orbit). For biological effects 124 eV is the more general 
norm where  radiation  is  considered  causing  biological  effects  (Hall  1994).  Furthermore, 
excitation  (raising one of  the electrons  in  an atom or  molecule  to  a  higher  energy level 
without ejection of the electron) in the target through which the radiation traverses can also 
occur.  Both  particle  radiation  (electrons,  protons,  alpha  particles,  or  neutrons)  and 
electromagnetic radiation (high energetic photons such as X- and gamma rays) belong to the 
category of ionizing radiation. 
The type  of  radiation  called  “non-ionizing  radiation”,  e.g.  UV and visible  light, 
infrared radiation and micro- and radio waves, does not produce ionizations and excitations 
when  interacting  with  matter  but  will  interact  with  many  cellular  components  through 
photochemical  reactions.  An example  of  damage caused by non-ionizing  radiation  is  the 
redness of the skin caused by exposure of UV radiation, which induces pyrimidine dimers in 
the DNA- molecule of the cell.
Important definitions, terms and units in radiation biology 
Cell damage can be related to the amount of energy absorbed in the cell and is called 
the  dose  of  radiation (quantity  of  absorbed  energy  in  matter  (J/Kg)  =  absorbed  dose), 
measured in  gray  (Gy).  The  dose  rate is  the  absorbed  dose  divided  by  the  time  of  its 
delivery. Due to limitations of the repair capacity in a living cell per unit of time, high dose 
rates are usually more damaging.
When  ionizing  radiation  is  absorbed  in  a  biological  material  there  is  a  random 
distribution of ionizations and excitations along the tracks of the charged particle in a pattern 
that is dependent on the type of radiation concerned, where e.g. X-rays are considered as 
sparsely ionizing radiation and 500 keV protons are densely ionizing radiation.  There are 
large differences  in ionizations between different types  of radiations.  In other words,  the 
linear  energy  transfer (LET)  values  for  different  types  of  radiation  illustrate  the  mean 
energy released in keV per micrometer (μm) of the tissue traversed (keV/μm). Example of 
low LET (sparsely ionizing) and high LET (densely ionizing) radiation are X- and gamma 
rays  and  energetic  neutrons,  protons  and  heavy  charged  particles  respectively.  The 
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demarcation  between low and high LET is  10 keV/μm.  The  equivalent  dose relates  the 
absorbed dose (Gy) in tissue to the biological effects of a specific radiation quality. The unit 
for equivalent dose is sievert (Sv). To determine equivalent dose (Sv), an absorbed dose (Gy) 
is multiplied by a radiation quality factor (Q). For example 1 Gy equals 1 Sv for gamma 
radiation (Q for gamma is 1), 1 Gy equals 20 Sv for alpha particles (Q for alpha is 20). 
Typical energy from gamma ray decay is several million eV. In biological tissue, the mean 
energy needed to create one ionization is about 16 eV. Alpha particles belong to high-LET 
and they can penetrate a tissue of paper (or skin) and travel only a few centimeters in air but 
generates a dense track of ionizations, which results in greater damage to the cell. High-LET 
radiation is therefore considered to be far more harmful than low-LET radiation (Figure 1).
Figure 1. An illustration of different types of radiations (from: Meijer AE. 1999. ISBN 91-
7153-844-4).
Cellular damage
It has long been known that DNA is the major target for biological effects of radiation 
(Hall 1994). DNA damage is generated through direct and indirect effects. For direct effects, 
ionizing radiation may deposit its energy directly to a DNA molecule in a cell, where the 
target itself can be ionized or excited. Direct effects are most frequent in cells exposed to 
high LET radiation. The direct effect contributes 30% of the radiation induced DNA damage. 
(Reuvers et al.1973). Alternately,  the radiation may also induce damage by ionizing other 
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molecules in close association with DNA in the cell,  which is referred to as the  indirect 
effect. This indirect effect of DNA damage is dominant, since a cell consists of about 70% 
water, and hence mostly water molecules are ionized. This process is called radiolysis  of 
water, in which extremely reactive and short-lived water products are made, free radicals. 
The main products of radiolysis  are hydroxyl  radicals  (OH•),  hydrogen radicals  (H•) and 
solvated electrons (e-aq). Free radicals have unpaired electrons and they react rapidly with 
everything close by such as other water molecules, cellular proteins, membranes, organelles, 
and the most critical target, DNA molecules by breaking chemical bonds. A lot of the cell 
damage caused by low LET radiation is of this indirect type.
 The damage of the cell can be lethal (the cell dies) or sub-lethal (the cell can repair 
itself).  The  effects  on  cells  can  be,  according  to  the  International  Commission  on 
Radiological Protection (ICRP), deterministic and stochastic.  Deterministic effects have a 
threshold of irradiation under which they do not appear and are the necessary consequence of 
irradiation. The damage they cause depends on the dose: they are sub lethal from 0,25 to 2 Sv 
(a less pronounced form of disease), lethal from 2 to 5 Sv (a certain percent of population 
dies in 60 days), above 5 Sv the majority of people die in 60 days and above 6 to 7 Sv all 
people die. Of course, these effects depend also on many other factors, like age, sex, health 
etc.  Stochastic effects are coincidental and can not be avoided. They have not a threshold. 
These can be divided into somatic and genetic. Among the  somatic ones, the  cancer is the 
most important. It develops because radiation causes DNA mutations directly and indirectly. 
The  genetic confer  the predisposition to  cancer  to the  offspring.  They are  not  very well 
understood.
DNA lesions of biological importance
Radiation induced DNA damage can be due to both indirect  and direct  effects  of 
radiation. The hits can occur on either the phosphate backbone, sugar group or on the base, 
resulting  in  single  strand  breaks  (SSBs,  1000  breaks/cell  per  Gy),  double  strand  breaks 
(DSBs, 20-40 breaks/cell per Gy), and base modifications (1000 modifications/cell per Gy) 
(Czene and Harms-Ringdahl 1995, Goodhead 1994, Pouget et al. 1999, Svoboda and Harms-
Ringdahl  2005).  A  particular  feature  of  radiation  induced  chemical  alterations  is  the 
production of unique types of multiple damages sites (MDS), consisting of clusters of strand 
breaks  and  base  damages  within  one  or  two  turns  of  the  DNA  (10  to  20  base  pairs) 
(Goodhead et al. 1993, Sutherland et al. 2001), they are suggested to be a specific signature 
of ionizing radiation. 
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The most  dangerous lesions are the DNA DSBs induced by X-rays,  chemicals  or 
during replication of SSBs. DSBs are generated when the two complementary strands of the 
DNA double helix are broken simultaneously at sites that are sufficiently close to one another 
that  base-pairing  and  chromatin  structure  are  insufficient  to  keep  the  two  DNA  ends 
juxtaposed. As a consequence, the two DNA ends generated by a DSB are liable to become 
physically  dissociated  from one  another,  making  ensuing  repair  difficult  to  perform and 
providing the opportunity for inappropriate recombination with other sites in the genome. 
Two SSBs can theoretically induce a DSB depending on the distance between them. 
DSBs may also create during replication due to an SSB encountered at the replication fork 
with the fatal consequence of a collapse of the replication fork. DSBs are also important for 
normal biological functions and are created in a controlled way in cells during meiosis, DNA 
replication and recombination processes. Probably the best characterized example of this in 
higher  eukaryotes  is  the  V(D)J  recombination  pathway  in  the  maturation  process  of 
developing B- and T-lymphocytes to provide the basis for the antigen-binding diversity of 
the immunoglobulin and T-cell receptor proteins. (Weinert 1998, Zhou and Elledge 2000). 
Cell cycle and its checkpoints
As cells  progress  through the cell  cycle,  they undergo several  transitions  that  are 
coordinated in time and order. The cycle is divided into four major parts; the G1 phase, the 
gap before DNA replication which determine the readiness of the cell and thereby preventing 
the  cell  from progressing  too  early  into  the  next  step;  the  S  phase,  the  period  of  DNA 
synthesis; the G2 phase, the gap between S and M, and M phase, the mitotic phase. There is 
also a G0 phase were the cell stays in a quiescent state. The G1-, S- and G2 phases form the 
interphase.  While  cells  are  in  the S phase of the cell  cycle  they duplicate  their  genome. 
Several biochemical processes in the cytoplasm determines timing and completion of the cell 
cycle.  Following the S and G2 phases, division starts within the M phase that includes a 
separation of the duplicated chromosomes and the formation of two daughter cells.
DSBs are the most critical lesions due to their high cytotoxicity and genotoxicity and, 
if they occur during the replication of the genome and during the segregation of duplicated 
chromosomes into daughter cells, broken chromosomes are carried through mitosis, and the 
acentric chromosome fragments will not be segregated between daughter cells.  Therefore, 
eukaryotes  have  developed  several  checkpoints  to  prevent  cells  from  starting  DNA 
replication (the G1/S checkpoint), from progressing with replication (the intra S checkpoint) 
or from going into mitosis (the G2/M check-point), if they contain damaged DNA (Dasika et 
10
al 1999, Zhou and Elledge 2000). However, it has become clear that DNA damage-induced 
cell  cycle  checkpoint  pathways  actually regulate  several  other events and, moreover,  that 
various aspects of these responses may even take place in cells that are not actively dividing 
(Jackson, 2002).
The actions  initiated  by the Ataxia  Telangiectasia  (ATM) kinase on activation by 
DSBs are multiple and complex (Rotman and Shiloh 1998). Part of the signal- transduction 
cascade is  mediated by the p53 protein,  which is  phosphorylated in response to  ionizing 
radiation  in  an  ATM-dependent  fashion.  In  humans  and mice,  deletion  of  the  gene  that 
encodes  p53  results  in  a  defective  G1/S  cell  cycle  checkpoint  and  a  reduced  apoptotic 
response upon irradiation. Mice harbouring a homozygous Trp53 deletion develop T-cell-
derived tumours at a young age (Donehower et al. 1992). Furthermore, most human tumours 
also contain somatically acquired mutations in the TP53 gene, which encodes p53, and the 
Li-Fraumeni syndrome (which is characterized by a high tumour incidence) can be caused by 
a  heterozygous  TP53  mutation,  underlining  the  importance  of  this  gene  for  tumour 
prevention (Dasika et al. 1999). 
Another phosphorylation target of ATM is the chromatin component H2AX. It is a 
variant of histone H2A and its phosphorylation is an early response to DSBs (Rogakou et al. 
1998). Phosphorylated H2AX is found in foci at which other DSB-repair-proteins, including 
RAD50 accumulate over time (Paull et al. 2000). At least one other phosphatidylinositol-3-
OH kinase (PI (3) K) family member, DNA dependent protein Kinase (DNA-PK, also known 
as  PRKDC),  has  been  implicated  in  H2AX phosphorilation  (Rogakou et  al.  1998).  This 
redundancy suggests that H2AX phosphorilation might be crucial for the cellular response to 
DSBs. Finally,  under conditions where the extent of DNA damage is too great;  cells can 
instead enter an apoptotic programme. Although the details of how this solution is reached 
are  not  yet  clear,  it  appears  that  this  pathway involves  the  actions  of  proteins  that  also 
function in other aspects of the DNA-damage response (Rich et al. 2000, Hirao et al. 2000, 
Herzog et al. 1998).
Repair mechanisms
Among the various stress responses induced by damage to DNA perhaps the most 
understood are the various forms of the DNA repair (Barzilay et al. 1995). The significance 
of  DNA repair  is  illustrated  by  the  phenotypes  of  xeroderma  pigmentosum,  Cockayne´s 
syndrome, trichothiodystrophy and hereditary non polyposis colorectal cancer patients (de la 
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Chapelle  and Peltomaki,  1995).  These  disorders  are  caused by mutations  in  DNA repair 
genes that predispose the patients to cancer, neurological abnormalities or both. 
All eukaryotes have evolved several mechanisms to deal with DSBs, which indicates 
the importance and difficulty to repairing this  type  of DNA injury,  such as:  homologous 
recombination  (HR) and non-homologous  end joining (NHEJ) both involved in  repair  of 
DSBs; base excision repair (BER) acting on base damages and SSBs; nucleotide excision 
repair  (NER)  mainly  involved  in  removal  of  bulky  adducts  (induced  by  chemicals)  and 
thymidine dimmers (induced by UV light);  and the pathway of nucleotide incision repair 
(NIR) that is involved in repair of base damages (Wood et al. 2005).
Radiation induced chromosomal alterations
Ionizing radiation is a strong clastogen, causing chromosome breakage and resulting 
in cytogenetic aberrations in exposed cells (Natarajan and Obe 1978, 1984, Goodhead 1994, 
Ward  1995).  When  high  LET radiation  (particle)  or  low LET radiation  (photon)  passes 
through the nucleus, in the case of high LET radiation, the ionizations occur close together. 
Ionization  within  a  chromosome  may  result  in  a  break  in  the  DNA.  If  such  breaks  are 
improperly repaired, they may be resolved as either stable (pericentric inversion) or unstable 
chromosomal aberrations (centric ring and acentric fragment) as illustrated in Figure 2. The 
same dose of low LET radiation will create more diffuse damage from a larger number of 
photon  tracks  with  ionization  events  occurring  further  apart,  resulting  in  fewer  multiple 
lesions within the same chromosome. When two or more different damaged chromosomes 
interact to resolve breaks, different types of stable (translocation) and unstable (dicentric and 
acentric fragment) aberrations result.
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Figure 2. Representation of radiations of different quality interacting with chromosomes in a 
cell nucleus. The dashed arrows represent the track of a particle or photon passing through 
the nucleus. (From: Amundson et al. 2001. Expert Rev Mol Diagn 1: 89-97).
Chromosome types aberrations: unstable aberrations
Dicentrics
The dicentric is the main aberration used for biodosimetry. It is an exchange between 
the  centromeric  pieces  of  two  broken  chromosomes,  which  in  its  complete  form  is 
accompanied  by  a  fragment  composed  of  the  acentric  pieces  of  these  chromosomes. 
Particularly  after  high  doses,  multicentric  configurations  can  be  formed.  Tricentrics  are 
accompanied by two fragments, quadricentrics by three fragments, etc.
Centric rings
In  human  lymphocytes,  centric  rings  are  much  rarer  than  the  dicentrics.  Some 
researchers  combine  them  with  dicentrics  while  others  choose  to  ignore  them  for  dose 
estimation. The ring chromosome is an exchange between two breaks on separate arms of the 
same chromosome and is also accompanied by an acentric fragment. 
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Acentrics
Acentric aberrations can be formed independently of the exchanges described above 
and as such are usually referred to as excess acentrics. They can be terminal or interstitial 
deletions of varying sizes but it is not always possible to determine their origin and so they 
are combined. Minutes, which appear as double dots and acentric rings where clear spaces 
may be seen within the dots, are normally considered to be interstitial deletions; this has been 
confirmed by telomere probing (Fomina et al. 2000).
Chromosome types aberrations: stable aberrations
Reciprocal translocations
The reciprocal (or complete or two-way) translocation is the exchange of terminal 
portions  of  two  separate  chromosomes.  Using  the  G-banding  technique  and karyotyping 
originally described the various types of translocation, but this procedure is too laborious for 
routine biodosimetry. With solid Giemsa staining, translocations are not observed reliably. 
Their application to dosimetry is possible with the fluorescence in situ hybridization (FISH) 
method; by the FISH method these are visualized as bicoloured monocentric chromosomes.
Non-reciprocal translocations
When only one bicoloured chromosome can be seen, this  has often been called a 
terminal,  or  incomplete,  or  one-way  translocation.  However,  using  a  combination  of 
chromosome  painting,  centromeres  and  telomere  probes,  a  number  of  translocations 
designated as terminal or incomplete was found to be in reality reciprocal. It is very likely 
that the signal of the missing counterpart is below the limit of visual resolution, and it has 
therefore been suggested to designate such patterns as one-way exchanges or translocations. 
The current view is that true terminal translocations do exist but they form a small percentage 
of the total, e.g. at 4 Gy they are about 5% (Fomina et al. 2000).
Interstitial translocations (insertions)
It is a bicoloured chromosome where an acentric piece of one chromosome has been 
inserted within an arm of another chromosome.
Apoptosis
When the burden of genomic insult is too large to be effectively repaired, cells are 
able to initiate programmed cell death, thereby eliminating themselves from a population that 
otherwise might suffer serious pathological consequences (Harms-Ringdahl et al. 1996, Cory 
and Adams, 2002).
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As aberrant regulation of apoptosis is often observed in cancer cells, the mechanism 
of  apoptosis  response  elicited  by  chemotherapeutic  drugs  and  ionizing  radiation  are  of 
interest for the design of new strategies for cancer treatment (Martin et al. 1994). Intensive 
chemotherapy  regimens  using  citotoxic  agents  do  effectively  kill  certain  malignancies, 
especially of hematopoietic origin and some solid cancers. However, malignant tumours are 
often resistant to chemotherapy and even develop acquired chemo-resistance or show multi-
drug resistance as a consequence of the previous treatment.  Thus development of chemo-
resistance remains a major obstacle for curable cancer treatment.
Apoptosis, a genetically programmed form of cell death, is a physiological event that 
is involved in development, elimination of unwanted cells and homeostasis of multicellular 
organisms, and is distinct from necrosis, the consequence of accidental cell death inducing 
substantial inflammatory responses (Wyllie et al. 1980).
Apoptosis is characterized by distinct morphological changes, e.g., condensation of 
chromatin at the nuclear periphery, surface membrane blebbing, and cell shrinkage (Falcieri 
et al. 1994, Gomez-Angelats et al. 2000). These changes are accompanied by a number of 
biochemical alterations, where activation of caspases (cysteine  aspartate-specific proteases) 
plays a central role. 
Activation of caspases, a family of cysteine proteases which specifically cleave at 
aspartic  acid  residues,  is  a  central  event  to  the  execution  of  apoptosis  (Thornberry  and 
Lazebnik  1998)  and  occurs  by  two  major  pathways:  one  involves  dysfunction  of 
mitochondria  in  response  to  a  variety  of  stresses  such  as  UV irradiation,  withdrawal  of 
growth factors, and genotoxic stimuli including treatment with chemotherapeutic agents; this 
pathway involves initiator  caspase 9 and cytochrome  c released to cytoplasm (Green and 
Reed, 1998). A second pathway is mediated directly by death-inducing membrane receptors 
(death  receptors)  upon  engagement  with  their  cognate  ligands  (death  ligands)  through 
activation of caspases 8 or 10 (Ashkenazi and Dixit 1998).
The notion that the caspases are involved in apoptosis emerged from the use of the 
nematode  Caenorhabditis elegans.  Genetic studies revealed that 131 cells out of 1,093 die 
during the development of the worm and that a specific set of genes are required for this 
process to occur. Cell death is induced by  ced-3, ced-4,  and egl-1 and inhibited by  ced-9 
(Horvitz 1999). The products of these four genes have counterparts in mammals. Thus, ced-3 
is homologous to mammalian caspases. Caspases are synthesized as inactive precursors and 
undergo proteolytic maturation upon apoptosis induction. Ced-4 is an adaptor protein that is 
necessary for Ced-3 activation. The mammalian homolog of Ced-4 in mammals is Apaf-1 
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(apoptotic protease activating factor-1), which together with cytochrome c and dATP recruits 
pro-caspase-9 to form the so-called  “apoptosome”,  the pro-caspase-9 activation  complex. 
Ced-9 is an anti-apoptotic protein homologous to the human oncoprotein Bcl-2. In mammals, 
several  proteins  similar  to  Bcl-2  have  been  discovered,  all  carrying  at  least  one  “Bcl-2 
Homology” (BH) domain. Bcl-2 family members are both anti-apoptotic (Bcl-2, Bcl-XL, Bcl-
w) and pro-apoptotic. Some of the pro-apoptotic members have three BH domains in their 
sequence (Bax, Bak, etc.), whereas others like Bim and Bid carry only one domain and for 
this reason are called “BH3-only”. The homologs of C. elegans pro-apoptotic protein Egl-1 
stand  in  the  “BH3-only”category.  In  C.  elegans,  Egl-1  interacts  with  Ced-9,  thereby 
dissociating  the  interaction  between Ced-9 and Ced-4.  Ced-9  is  a  mitochondrial  protein, 
which normally tethers Ced-4 to mitochondrial membranes. Upon expression of Egl-1, Ced-4 
dissociates  from mitochondria  and associates  with the  nuclear  envelope.  Moreover,  once 
released, Ced-4 interacts with Ced-3 to cause its activation. It would be incorrect, however, 
to assume that caspase activation in mammals follows the same rules as those established in 
C.  elegans.  Thus,  the  mammalian  Ced-4  and  Ced-9  equivalents,  Apaf-1  and  Bcl-2  like 
proteins, do not interact physically, and Apaf-1 is actually a cytosolic (not a mitochondria-
associated) protein (Haraguchi et al. 2001). Moreover, Apaf-1 possesses WD domains which 
are missing in Ced-4 and which need to interact with cytocrome c so that Apaf-1 can trigger 
caspase activation. Apoptosis is often referred to as a caspase-dependent process. However, 
certain forms of apoptosis have been shown to be caspase-independent (Leist and Jaattela 
2001). Nevertheless, recent work has provided evidence that mitochondria play an important 
role in both caspase-dependent and independent forms of apoptosis.
DNA  damage,  Kinase  inhibition,  trophic  factor  deprivation,  ischemia,  ultraviolet 
radiation  and  oxidative  stress  are  some  of  apoptotic  signals  channelled  through  the 
mitochondria. There are several factors relaying death stimuli to the mitochondria, the most 
studied of these are the BH3-only Bcl-2 family members and the pro-apoptotic protein Bax. 
Upon reception of apoptotic stimuli, these proteins translocate from the cytosol to the 
mitochondria. Interesting examples of such translocating proteins are Bid and Bim (which 
mediate the cell surface death receptor and trophic factor deprivation mitochondrial apoptotic 
responses,  respectively  and  PUMA  or  Noxa  (which  mediates  the  p53-dependent  death 
response  to  DNA damage,  (Oda et  al.  2000,  Nakano and Wousden 2001),  which,  when 
activated, translocate to the mitochondria, where they interact with the proteins of the Bcl-
2/Bcl-XL or Bax/Bak subfamilies to induce to release of apoptogenic mitochondrial proteins. 
Studies  have  also  shown  that  two  transcriptional  activators,  p53  and  TR3,  target 
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mitochondria in response to DNA damage in the nucleus. TR3, an orphan receptor from the 
steroid/thyroid receptor family, has been shown to relocate from the nucleus to the surface of 
the mitochondria, where it triggers the release of cytochrome c (Li et al. 2000). In contrast, 
p53 increases the expression of pro-apoptotic Bcl-2 family proteins. Potential transcription-
independent  functions  of  p53 co-operate  with the  Bcl-2  protein  to  induce  the  release  of 
apotogenetic factors from the mitochondrial outer membrane. Released apoptogenic factors 
facilitate the activation of the effectors caspases through the Apaf-1-caspase 9-apoptosome. 
In addition, alternative pathways of p53-dependent caspase activation such as by generation 
of reactive oxygen species (ROS) have been postulated (Polyak et al. 1997, Li et al. 1999). 
However, using experimental systems, ROS inhibitors failed to protect against p53-mediated 
apoptosis (Shuler et al. 2000), and the generation of ROS appeared to occur downstream of 
p53-induced caspase activation. In conclusion, the intrinsic apoptotic pathway (Figure 3.) is 
both necessary and sufficient  for stress-induced and p53-dependent  caspase activation  in  
vitro and  in vivo  and it appears that a wide range of cell death stimuli are relayed to the 
mitochondria  by  proteins  that  translocate  to  the  organelle  and  trigger  the  apoptotic 
mitochondrial response.
Figure 3. Summary of the pathways of p53-dependent apoptosis (from: Schuler and Green. 
2001. Biochemical Society Transactions 29: 684-687).
Other  important  features  of apoptotic  cells  are  fragmentation  of DNA progressing 
from high molecular weight (300-700 kbp) fragments (Bicknell et al. 1994) to fragments of 
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size around 50 kpb (Zhivotovsky et  al.  1994) and variations in Mitochondrial  Membrane 
Potential  (∆ψ) generated by mitochondrial  electron transport chain which drives a proton 
flow from matrix  through  inner  mitochondria  membrane  to  cytoplasm,  thus  creating  an 
electrochemical  gradient.  This  gradient  is  in  turn  responsible  for  the  formation  of  ATP 
molecules  by  Fo-F1 ATP  synthase.  For  this  reason  ∆ψ is  an  important  parameter  for 
mitochondrial functionality and an indirect evidence of energy status of the cells.
Most  rec e ntly  has  be e n  descri b e d  the  end o pl as m i c  reticulu m  (ER) path w a y  of  
apopto sis  w hi c h  ma y  be  interc o n n e c t e d  with  the  others.  The ER regulates protein synthesis, 
protein folding, and calcium homeostasis (Rao et al. 2004). Cellular Ca2+ import through the 
plasma membrane occurs largely by receptor-operated, voltage-sensitive and store-operated 
channels (SOCS). Once inside the cell, Ca2+ can either interact with Ca2+ binding protein or 
become sequestrated into the ER or mitochondria. The largest Ca2+ store in the cell is found 
in the ER. Ca2+ levels  in the ER are affected by the relative distribution of sarco (endo) 
plasmic reticulum Ca2+- ATPase (SERCA) pumps and of inositol  1,4,5-trisphosphate  (ins 
(1,4,5)  P3)  receptor  (IP3R) and rhyanodine  receptors  (RYRs),  as  well  as  by the  relative 
abundance of Ca2+ binding proteins (calreticulin an calsequestrin) in the ER. The cytosolic 
Ca2+  concentration in unstimulated cells is kept at ~100 nM by both uptake in the ER and 
efflux by plasma membrane  Ca+-ATPase (PMCA) pump.  The mitochondria  take-up Ca2+ 
through  a  uniporter  channel,  which  has  high  affinity  for  Ca2+.  Bcl-2  proteins  are  key 
regulators of apoptosis.
Several ER member proteins interact  with Bcl-2 family members and influence apoptosis 
(Orrenius et al. 2003). Bcl-2-associated protein-31 (BAP31), a 28-kDa integral protein of the 
ER, contains a cytosolic domain that interacts preferentially with pro-caspase-8, Bcl-2 and 
Bcl-xL.  Active  caspase-8  can  cleave  BAP31,  with  amino  terminal  fragment  remaining 
integrated  in  the  ER  and  involved  in  induction  of  apoptosis.  There  is  now  convincing 
evidence that the release of Ca2+ from the ER stores, followed by its translocation into the 
mitochondria, is an important signal for the activation of apoptosis process. Several studies 
indicate that depletion of ER Ca2+ stores correlate better with induction of apoptosis than the 
resultant capacitative influx of extracellular Ca2+ or the overall increase in intracellular Ca2+. 
Bcl-2  targeted  to  ER is  capable  of  blocking  most,  although  not  all,  types  of  apoptosis. 
Furthermore, there is an existence of apoptotic cross talk between the ER and mitochondria, 
controlled  by  the  ER-localized  Bcl-2.  Prolonged  ER  stress  stimulates  the  activation  of 
procaspase- 12 (Orrenius et al. 2003). Pro-caspase 12 is localized in the ER membrane and is 
activated  and  cleaved  by  m-calpain  during  ER stress,  or  in  response  to  mobilization  of 
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intracellular  Ca2+ stores.  Once  activated  caspase-12  acts  on  effector  caspases  to  induce 
apoptosis. Therefore, these findings indicate that ER stress, as caused by calcium depletion or 
alterations  in  the  Ca2+ transport  system,  the  sarcoendoplasmic  reticulum  Ca2+-ATPase 
(SERCA) pump and the IP3R, can be linked directly to caspase activation. Alterations in Ca2+ 
homeostasis  and  accumulation  of  misfolded  protein  in  the  ER  cause  ER  stress,  which 
ultimately lead to apoptosis. A role of intracellular Ca2+ in the apoptosis of thymocytes is 
well established (Cohen and Duke 1984, Wyllie 1980); however, its role in T cell subsets has 
not been explored.
Induction of apoptosis appears an important determinant of cancer cell sensitivity to 
chemotherapeutic agents. Since chemotherapy-induced tumour cell killing is associated with 
mitochondrial  damage,  activation  of  death  ligand/receptor  pathways  could  provide  a 
therapeutic strategy to combat malignant tumours, perhaps even those with high levels of 
chemoresistence.
Even thought  apoptosis  is  a very straightforward and effective mechanism of cell 
disposal;  several  reports  indicate  its  reversibility  up  to  certain  point  of  progression.  For 
instance, radiation-induced apoptosis of human peripheral blood lymphocytes (HPBL) can be 
counteracted by the addition of mitogens (Stewart et al. 1988, Carloni et al. 2001), or growth 
factors  (Meijer  et  al.  1999).  Lymphocyte  homeostasis  is  a  balance  between lymphocytes 
proliferation  and  lymphocytes  death.  Tight  control  of  apoptosis  is  essential  for  immune 
function, because its altered regulation can result in cancer and autoimmunity. Signals from 
members of the tumour-necrosis-factor receptor (TNF-R) family, such as Fas and TNF-R1, 
activate the caspase cascade and result in lymphocytes death by apoptosis. Anti-apoptotic 
proteins,  such  as  FLIP  (also  known  as  FLICE/caspase-8  inhibitory  protein)  have  been 
identified. FLIP expression is tightly regulated in T cells and might be involved in the control 
of both T-cell activation and death. Abnormal expression of FLIP might have a role not only 
in  autoimmune  diseases,  but  also  in  tumour  development  and  cardiovascular  disorders 
(Thome and Tschopp 2001).
It can be hypothesized that residual DNA strand breaks from abortive apoptosis might 
interact and give rise to chromosomal aberrations.  Apoptosis  is  a  physi ol o g i c a l  proc e s s  of  
cell  death  that  oc curs  during  e m b r y o g e n e s i s,  m eta m o r p h o s i s  and  tissue  atrophy  and  tum o ur  
regressi o n.
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Biological dosimetry
Biological dosimetry, based on the analysis of dicentric chromosomes, has been used 
since  the  mid  1960s.  The  intervening  years  have  seen  great  improvements  bringing  the 
technique  to  a  point  where  dicentric  analysis  has  become  a  routine  component  of  the 
radiological protection programmes (IAEA 1986). Experience of its application in thousands 
of cases of actual or suspected overexposures has proved the worth of the method and also 
helped to define its limitations.
Chromosomal aberrations in lymphocytes are used as a dosimeter and provide a very 
important  input  into  the  compendium  of  information  that  needs  to  be  collected  and 
considered when a radiological accident is investigated (Turai 2000).
In  the  investigation  of  radiation  accidents  it  is  important  to  estimate  the  dose  to 
exposed  persons  for  several  reasons.  In  the  case  of  high  exposures  (>1  Gy  acute), 
information on doses assists in the planning of therapy and in alerting physicians to likely 
deterministic health consequences that could arise in the following weeks and months. For 
exposures below the level where treatment is needed, dosimetric information is important for 
the physician in counselling irradiated persons on the risk of their developing late stochastic 
diseases — i.e. cancer. 
For  persons  whose  exposure  is  very  low  (<50  mGy),  the  knowledge  that  no 
significant elevation in chromosomal damage could be found is frequently very reassuring. 
This is particularly the case where details of events are poorly known and no physical dose 
measurements  or  calculations  are  available.  Then  biological  dosimetry  may  be  the  only 
means of quantifying dose, although there is quantification problems associated with factors 
such as non-uniform exposures, intake of radionuclides and delayed blood sampling.
Biological dosimetry also has a valuable role to contribute in the early period after an 
accident where many persons may have been exposed. At this time, triage of casualties using 
biological  and  clinical  endpoints  that  initially  and  rapidly  can  give  just  an  approximate 
estimate of dose is needed.
Radiation sensitivity
Radiosensitivity is the relative susceptibility of cells, tissues, organs or organisms to 
the harmful effect of ionizing radiation. Cells are least sensitive when in the S phase, then the 
G1 phase, then G2 phase and the most sensitive in the M phase of the cell cycle as described 
by the law of Bergonie and Tribondeau, formulated in 1906: "X-rays are more effective on 
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cells which have a greater reproductive activity." From their observation, they concluded that 
quickly dividing  tumor cells are generally more sensitive than the majority of body cells. 
This is not always true. Tumor cells can be hypoxic and therefore less sensitive to X-rays that 
mediate most of their effects through free radicals produced by ionizing oxygen. Later it has 
been shown that the most sensitive cells are those that are undifferentiated, well nourished, 
divide  quickly  and  are  highly  metabolically active.  Amongst  the  body  cells,  the  most 
sensitive  are  spermatogonia and  erythroblasts,  epidermal  stem cells,  gastrointestinal  stem 
cells. Very sensitive cells are also oocytes and lymphocytes, although they are resting cells 
and do not meet the criteria described above. The reasons for their sensitivity are not clear. 
Radioresistant  tissues  are  brain,  muscle,  liver,  lung  and  kidney  (Gudkov and  Komarova 
2003). 
Different genes are involved in the different DNA repair mechanisms and inactivation 
of  these  genes  result  in  changes  in  the  radiation  sensitivity  of  the  cell  (Hall  1994). 
Furthermore,  some  causes  of  radiosensitivity  are  inherited  genetic  disorders.  The  best 
described disorder is  ataxia  telangiectasia  (AT).  Those patients  have a  mutated  AT gene 
(ATM)  and  suffer  from  neuromuscular  degeneration,  dilated  ocular  blood  vessels, 
immunodeficiency, chromosomal instability, and a substantially increased incidence of some 
cancers (Hecht and Hecht 1990). Others are Nijmegen breakage syndrome, characterized by 
variable immune deficiencies, developmental delay,  chromosomal instability,  and a strong 
predisposition to lymphoid malignancy (Weemaes et al. 1981, Seemanova et al 1985, Barbi 
et  al.  1991,  van  der  Burgt  et  al.  1996),  Bloom’s  syndrome,  a  rare  autosomal  recessive 
disorder with genetic  instability (Kuhn 1980, Aurias et  al.  1985),  and another  autosomal 
recessive disorder, Fanconi’anemia, most commonly presenting with acute myeloid leukemia 
(15,000-increased risk ) (Joenje et al. 1995).
Radiation and Radiotherapy
Radiation therapy is defined as the treatment of diseases (mostly malignant tumours) 
with ionizing radiation. In 1898 and 1899, just a few years after the discovery of X-rays in 
1895 by Wilhelm Roentgen, two Swedish scientists treated three patients with skin tumour 
by X-rays. One of the patients was treated once a day under three months and became the 
first  cancer  patient  who  was  cured  by  radiotherapy.  After  World  War  II  new  radiation 
equipments  with higher  energies  became available  allowing the treatment  of  deep-seated 
tumours. The new 60Co sources allowed shorter treatment times and almost all radiotherapy 
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clinics  in  the  world  used  these  sources  from 1950  until  1960.  At  the  end  of  1950-ties 
radiation  machines  with  energy  outputs  in  the  MeV  ranges  (linear  accelerators)  were 
introduced and are still the most common radiation equipments in clinical praxis.
The  use  of  new  radiotherapeutic  modalities  and  improvement  of  diagnostic 
techniques  such  as  computer  tomography  (CT),  positron  emission  tomography  (PET), 
magnet  resonance  imaging  (MRI)  and  ultra  sound  increased  the  possibilities  for  the 
oncologists to distinguish a tumour from a normal tissue and thus optimize the dose planning 
and  treatment  regimes.  Radiotherapy  can  be  used  alone  as  a  curative,  adjuvant  (in 
combination with surgery and chemotherapy)  or palliative (pain relieving) treatment.  The 
aim of modern radiotherapy is to cure patients from cancer with limited adverse effects to the 
normal tissue surrounding the cancer tumour. This can be achieved by carefully planning of 
the dose delivery to the tumour (dose planning system) and more detailed understanding of 
the tumour and healthy tissue responses to radiation.
For  many  years  it  has  been  recognized  by  clinicians  that  some  patients  show 
hypersensitivity to the radiotherapy. During the radiotherapy both cancer and normal cells 
are being exposed to the radiation. Radiation-induced damage in tissues may lead to the cell 
death, and toxic components from dead cells may affect the whole body causing symptoms. 
Therefore,  early and late  adverse effects  in exposed healthy tissues are the major factors 
limiting dose escalation in radiotherapy of cancer patients. The Radiation Therapy Oncology 
Group  (RTOG)  is  the  most  commonly  used  system,  based  on  the  intensity  of  the 
deterministic effects (acute as well late effects) on tissues, for evaluation of radiosensitivity 
in a patient.  At the present time,  doses used in radiotherapy are adapted to what can be 
tolerated by the most radiosensitive patients  (with severe persistent normal tissue damage 
below 5-10%); despite the fact that many patients could tolerate a larger dose without severe 
tissue reactions. Therefore, information on individual radiosensitivity would greatly benefit 
radiotherapy. 
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THE AIM 
The aim of this thesis was to understand the relationships between apoptosis and the 
final outcome of DNA damage in human cells. 
In particular:
• The  relationships  between  the  frequencies  of  radiation-induced  chromosomal 
alterations and the extent of apoptosis in G0 human lymphocytes (paper I); 
• A direct  role  of  apoptosis  in  eliminating  irradiated  G0 human  lymphocytes,  once 
prematurely condensed, bearing dicentric chromosomes (paper II); 
• To  investigate  the  effect  of  storage  conditions  of  human  whole  blood  to  retain 
viability of lymphocytes (paper III);
• The role  of  apoptosis  in  human bladder  cancer  cell  lines  treated  with a  potential 
anticancer drug “STDS2323” (paper IV). 
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PRESENT INVESTIGATION
Cell types employed 
Whole Blood (Paper III)
Human  peripheral  blood  samples  were  collected  by  venipuncture  from  healthy 
individuals  into multiple  vacutainers  (greiner  bio-one GmbH,  Austria)  containing  lithium 
heparin.  Donors  gave  their  informed  consent  and  the  ethical  committee  of  the  Belcolle 
Hospital approved the experiments. The whole blood was diluited 1:3 with fresh Roswell 
Park Memorial  Institute  1640 (RPMI 1640) culture  medium supplemented with  2mM L-
glutamine, 100 IU/ml of penicillin,  100 µg/ml streptomycin,  and 10% of heat-inactivated 
fetal bovine serum and 1% of Hepes (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 
(all from Gibco RL, Life Technologies, Europe) and aseptically transferred to test tubes.
When  appropriate,  the  cultures  were  stimulated  to  grow  with  2%  phytohaemagglutinin 
(PHA) (Murex Biotech Ltd, Dartford, UK). Stimulated (G1) and unstimulated (G0) whole 
blood samples were stored at 4°C or at 20°C or in a humidified atmosphere of 95% air and 
5% CO2 (37°C).
G0 lymphocytes (Paper I, II, III, IV)
Freshly  obtained  “buffy  coats”  from healthy  human  donors  were  obtained  at  the 
Belcolle  Hospital,  Viterbo,  Italy,  and at  Blood Donor Centre  of the Karolinska Hospital, 
Stockholm, Sweden. Donors gave their informed consent and the ethical committee of both 
Hospitals  approved  the  experiments.  G0 lymphocytes  were  isolated  by  separation  in 
Histopaque-1077  (Sigma,  Italy),  or  Ficoll-Paque  (Amersham  Pharmacia  Biotech  AB, 
Sweden) according to manufacturer´s instructions, and were cultured at a concentration of 3 
x 106 cells/ml in RPMI 1640 culture  medium supplemented with 2mM L-glutamine,  100 
IU/ml  of  penicillin,  100  µg/ml  streptomycin,  and  10  % of  heat-inactivated  fetal  bovine 
serum,  (all  from  Gibco  RL,  Life  Technologies,  Europe)  and  incubated  at  37ºC  in  a 
humidified atmosphere of 95% air and 5% CO2.
G1 lymphocytes (Paper I, III, IV)
When  appropriate,  G0 lymphocytes  were  stimulated  to  grow  with  2%  PHA  and 
cultured at a concentration of 3 x 106 cells/ml in RPMI 1640 culture medium supplemented 
with 1% L-glutamine, 100 IU/ml of penicillin, 100 µg/ml streptomycin, and 10 % of heat-
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inactivated  fetal  bovine  serum,  (all  from  Gibco  RL,  Life  Technologies,  Europe)  and 
incubated at 37ºC in a humidified atmosphere of 95% air and 5% CO2. 
Mitotic Chinese hamster ovary (CHO) cells (Paper II) 
CHO cells were routinely grown in Ham’s F-10 medium supplemented with 1% L-
glutamine, 100 IU/ml of penicillin, 100 µg/ml streptomycin, and 10% of heat-fetal bovine 
serum, (all from Gibco RL, Life Technologies, Europe). Log-phase cultures were arrested in 
mitosis with 0.2 μg/ml Colcemid (Gibco RL, Life technologies, Europe). Mitotic cells were 
collected by shake-off and frozen in culture medium supplemented with 10% of  Dimethyl 
sulfoxide (DMSO) (Sigma, Italy) and 0.2 μg/ml Colcemid.
TK6 and WTK1 (Paper IV)
These cell lines are derived from the same donor and differ in p53 activity, being p53 
gene mutated in WTK1 but not in TK6 cells (Amundson et al. 1993, Little et al.1995, Zhen et 
al. 1995, Xia et al. 1995). The TK6 and WTK1 human B lymphoblast cell lines have been 
described in detail elsewhere (Liber and Thilly 1982, Amundson et al. 1993). These cell lines 
were  maintained  under  conditions  of  exponential  growth  in  RPMI-1640  medium 
supplemented with 10% heat-inactevated horse serum (Bio-Whittaker), 2mM L-glutamine, 
100 μg/ml streptomycin and 100 units/ml penicillin. Cells were grown in suspension at 37°C 
in a humidified atmosphere of 95% air and 5% CO2 and sub cultured every 3 days to mantein 
cell density between 103 and 105 cells/ml.
RT112, MGH-U1 and U1-S40b (Paper IV)
Three bladder  cancer  cell  lines were used:  1) the RT112, radioresistant  originally 
established from a transitional cell carcinoma of the bladder at the Institute of Oncology of 
the  University  of  London  (Masters  et  al.  1986)  characterized  as  homozygous  for  p53 
mutations (Warenius et al. 2000); 2) the MGH-U1 radio-resistant cell line from a transitional 
bladder carcinoma (Kato et al. 1997), classified as expressing wild type p53 (Warenius et al. 
2000); and 3) the U1-S40b, radiosensitive clone of MGH-U1 (Mc Millan and Holmes 1991). 
Cells  were  grown  as  an  attached  monolayer  in  Dulbecco’s  Modified  Essential  Medium 
(DMEM)  supplemented  with  10%  fetal  bovine  serum,  2mM  L-glutamine,  penicillin 
(50U/ml),  and  streptomycin  (50μg/ml)  (all  from Gibco  RL,  Life  Technologies,  Europe). 
Cultures were kept at 37ºC in a humidified atmosphere of 95% air and 5% CO2.
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Assays used
Trypan Blue Exclusion (TBE) assay (Paper I, II, III, IV)
The TBE method is based on the differential uptake of the dye by living and non-
viable cells.  Equal volume of 0.4% (w/v) trypan blue was added to the cells  suspension, 
mixed  well,  and  scored  in  a  Bürker  chamber.  Viability  was  calculated  as  follows:  cell 
viability (%) = total viable cells (unstained) x 100/total cells (stained and unstained).
Fluorescence staining (Paper IV)
The apoptotic  cells  were detected  by fluorescence  microscopy.  A combination  of 
fluorescein di-acetate (FDA; 5 μg/ml), propidium iodide (PI, 0.5 μg/ml) and Hoechst (HO, 1 
μg/ml) dyes were used to detect the apoptotic and necrotic cells from viable cells. FDA and 
HO are vital dyes that stain the cytoplasm and the nucleus of the viable cells, respectively. 
The necrotic and the late stage of apoptotic cells are readily identified by PI staining. Cells in 
the early-phase (viable-HO stained) and late-phase (dead-PI stained) of apoptosis displayed 
the characteristic pattern of chromatin fragmentation. Approximately 2000 randomly chosen 
cells were microscopically analysed for apoptosis. 
Comet Assay (Paper IV)
The standard alkaline (pH > 13) single cell  gel electrophoresis  (SCGE), or comet 
assay, was performed according to the method developded by Singh and co-workers (1988). 
SCGE analyses were carried out under non-UV fluorescent light as described by Tice et al. 
(2000). Immediately after the treatment,  cells were collected and processed for the assay. 
Briefly, 20 μl of cell suspension (2 x 106 cells) was mixed with 180 µl of 0.75% low melting 
point agarose in phosphate buffer solution (PBS) at 37°C and was immediately pipetted on to 
a frosted glass microscope slide precoated with a layer of 1% normal melting point agarose, 
similarly prepared in PBS. Slides were then incubated in a lysis solution (2.5 M NaCl, 10mM 
Tris-HCl, 100 mM EDTA, pH 10, with 1% Triton and 10% DMSO added fresh) for 50 min.
After lysis, slides were placed on a horizontal electrophoresis unit containing fresh 
buffer  (1  mM  EDTA and  300  mM  NaOH,  pH 13)  and  incubated  for  15  min  to  allow 
unwinding of DNA. Elecrophoresis was then conducted in fresh electrophoresis buffer for 20 
min  at  25  V  and  300  mA  at  4°C.  Subsequently,  the  slides  were  gently  washed  in 
neutralization solution (0.4 M Tris-HCl, pH 7.5) for 5 min and fixed in 100% fresh methanol 
for 3 min. Slides were stained with 50 μl ethidium bromide (20 μg/ml) and covered with a 
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coverslip. Stained nucleoids were examinated at x400 magnification with an automatic image 
analyser  (Comet  Assay  III;  Perceptive  Instruments,  UK)  connected  to  a  fluorescence 
microscope  (Eclipse  E400;  Nikon).  To  evaluate  the  amount  of  DNA damage,  computer 
generated tail moment values and percentage of DNA damage were used. For each sample 
and for each treatment 100 cells were evaluated from two different coded slides.
JC-1 staining (Paper I, II, III) 
The  technique  of  JC-1  staining  has  been  developed  to  detect  variations  in 
mitochondrial  membrane potential  at  the single cell  or at  the single organelle level.  JC-1 
exhibits  potential-dependent  accumulation  in  mitochondria,  indicated  by  a  fluorescent 
emission shift from green to red (Reers et al. 1991, Smiley et al. 1991). Cells were stained 
with 1 µg/ml solution of JC-1 in RPMI 1640 culture medium for 15-20 min in the dark at 
room temperature, washed twice in phosphate buffered saline (PBS) and resuspended again 
in RPMI 1640 culture medium. Then, 40 µl of cell suspension was spread onto a microscope 
slide. The slides were coded and at least 200 cells/sample were counted under a fluorescence 
microscope using an appropriate filter. The cells were divided into 2 categories: normal cells- 
red; apoptotic cells- green. 
 
The Premature Chromosome Condensation (PCC) and the centromere-banding (C-banding) 
techniques (Paper II)
The PCC assay is the most sensitive method to detect radiation damage in interphase 
cells  (Pantelias and Maillie 1984, Hittelman and Rao 1974, Cornforth and Bedford 1983) 
using fusion of the test cells with mitotic cells, which transmit a signal for dissolution of the 
nuclear  membrane  and  condensation  of  interphase  chromosomes.  In  G0  prematurely 
condensed chromosomes the distinction of dicentrics is  difficult  due to their  morphology 
where  the  centromere  is  not  visible  and  only  one  chromatid  is  present. The  C-banding 
technique produces selective staining of constitutive heterochromatin located mostly at the 
centromeric  regions  of  chromosomes,  and hence the PCC method combined with the C-
banding assay allows examining chromosome-specific damage in the interphase scoring of 
dicentrics, centric rings and excess acentrics. 
The technique used was essentially that described by Pantelias and Maillie (1983). 
Briefly,  interphase lymphocytes  (7 x 106)  were fused immediately and 48 h after  X-rays 
exposure (3 Gy) with mitotic Chinese Hamster Ovary (CHO) cells (2 x 106). Control samples 
were processed simultaneously. Polyethylene-glycol (PEG molecular weight 1450, 55% w/v 
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in PBS) (Sigma, Italy) was used as a fusing agent. After fusion, the cells were incubated for 1 
h  in  a  complete  growth  medium  containing  Colcemid  (0.2  μg/ml)  at  37°C.  Air-dried 
preparations were made after hypotonic treatment (0.075 M KCl) and fixation with acetic 
acid and methanol (1:3). Slides were C-banded according to the method described by Sumner 
(1972) and stained with 5% Giemsa. The chromosomal aberrations were classified according 
to Savage (1975). Every polycentric PCC was considered as (number of centromeres – 1) 
dicentric. The excess in the frequencies of fragments with respect to the number of dicentrics 
was reported as excess acentrics.  For measurements,  75 well-spread C-banded cells  were 
analysed for each point. An automated search and relocation system (Metafer and Relosys, 
MetaSystems Hard & Software GmbH, Altlussheim, Germany) was used for scoring.
Isolation of lymphocytes (Paper I, II, III, IV)
G0 lymphocytes were separated from the concomitant erythrocytes and thrombocytes 
by centrifugation in Histopaque-1077 (Sigma, Italy) or Ficoll-Paque (Amersham Pharmacia 
Biotech  AB,  Sweden),  according  to  manufacturer´s  instructions.  Monocytes  and  other 
surface-active cells were removed by incubation in low-serum RPMI-1640 culture medium 
supplemented with 1% L-glutamine, 100 IU/ml of penicillin, 100 µg/ml streptomycin, and 
1% of heat-inactivated fetal bovine serum, (all from Gibco RL, Life Technologies, Europe) 
for 2 h at 37º C in a humidified atmosphere of 95% air and 5% CO2. Afterwards, the medium 
with the free-floating G0 lymphocytes was decanted into Falcon tubes and collected by 15 
min centrifugation at 100 g at room temperature. The cells were resuspended in fresh normal-
serum medium (the same as low-serum medium but with 10% of the inactivated fetal bovine 
serum) and incubated over night at the conditions indicated above.
Ficoll separation technique (Paper II)
This is a simple and reproducible technique for separating apoptotic (high-density) 
and normal (normal density) cells on the base of their sedimentation property reflecting their 
different cellular morphology (Czene et al.2002). Cells were divided by Ficoll gradient into 
high-density fraction termed as HD (the cell pellet at the bottom of the centrifugation tube) 
and normal density fraction termed as ND (the cells in the interphase layer). 
Chromosomal aberrations (Paper I)
Cells were arrested in metaphase with a 3 h treatment with Colcemid (0.2 μg/ml). 
Chromosome preparations were made by standard techniques after incubation in a hypotonic 
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solution  (0.075  M  KCl)  and  3:1  methanol/acetic  acid  fixation.  Air-dried  slides  were 
processed according to the Fluorochrome plus Giemsa (FPG) method by Perry and Wolff 
(1974)  in  order  to  score  only  first  cell  cycle  mitosis.  Chromosomal  aberrations  were 
classified according to  Savage (1975).  Every polycentric  chromosome was considered  as 
(number of centromeres –1) dicentrics and extra fragments as B”.
Mitotic index (Paper III)
Cells  stimulated to proliferate with 2% PHA  were placed for 56 h in a humidified 
atmosphere  of  95%  air  and  5%  CO2 (37°C)  and  supplemented  with  6  µg/ml  5-
bromodeoxyuridine (BrdUrd) (Sigma,  Italy).  Colcemid (0,2 µg/ml) was added 3 h before 
harvesting. Chromosome preparations were made by standard techniques after incubation in 
a hypotonic solution (0,075 M KCl) and 3:1 methanol / acetic acid fixation. Air-dried slides 
were processed according to FPG (Fluorochrome plus Giemsa) method by Perry and Wolf 
(1974) in order to evaluate the cell proliferation. The proliferation index (PI) is the average 
number of replications completed by metaphase cells and is calculated as follows:
PI = [(% first division metaphases + 2 x (% second division metaphases) + 3 x (% subsequent 
division metaphases)] / 100.
For each experimental point, the mitotic index was analysed on a total of 3000 cells 
(1000 cells per donor).
 
Flow cytometric assay for p53 expression (Paper I)
The expression of p53 protein was evaluated according to Kastan et al. (1991), who 
demonstrated that the amount of p53 protein detected by flow cytometry correlates well with 
that assessed by Western blotting or immunoprecipitation. For each experimental point, 2 x 
106 cells were fixed and permeabilized by the drop wise addition of 50% methanol/PBS and 
overnight incubation at –20°C. The cells were then washed twice in PBS and incubated for 
15 min in a blocking solution (0.2% Tween 20 plus 1% bovine serum albumin, BSA, in PBS) 
(PTA). After centrifugation, the cells were incubated for 1 h at +4°C with mouse monoclonal 
Ig-G2a anti-p53-antibody  (DO-1)  (Santa  Cruz  Bio  Technology,  Santa  Cruz,  CA,  USA) 
(diluted 1:6 in PTA). 
The  cells  were  washed  three  times  in  PTA,  incubated  for  1  h  at  +  4°C  with 
fluorescein (FITC) anti-mouse-Ig-G (H + L) (Vector Laboratories, CA, USA) (diluted 1:200 
in PTA), washed three times in PTA, stained with propidium iodide (PI) (5  μg /ml) (both 
from Sigma) in PBS and analysed on a fluorescence-activated cell sorter (FACS) Calibur 
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flow cytometer  (Becton-Dickinson,  San  Jose,  CA,  USA) equipped  with  a  Class  1  Laser 
operating at 488 nm wavelength and 15 mW of power. Data on relative changes in FITC 
(FL1H) and PI fluorescence (FL2H) (indicative of changes in p53 protein and DNA content, 
respectively)  were  obtained  and  analysed  using  Cell  Quest  software,  v.3.0  (Becton 
Dickinson, San Jose, CA, USA). p53 positive cells were calculated by gating the populations 
with FL1H > 101. Negative control for p53 protein expression was performed with untreated 
cells processed only with the secondary fluorescein anti-mouse antibody.
Agents used
Radiation (Paper I, II)
Irradiation with gamma rays was carried out in a 137Cs source (Scanditronix, Sweden) 
at a dose rate of 0.68 Gy/min; while irradiation with X-rays was carried out in a 250 KV and 
6mA Gilardoni (Italy) MGL 200/8 D X-ray apparatus at a dose rate of 0.6 Gy/min.
Cytosine arabinoside (Ara-C) (Paper I)
Inhibition  of  the  repair  process  by Ara-C (Dunn and Regan  1979,  Preston  1980, 
Collins et al.1982, Ahnstrom 1989, Zittoun et al. 1991) is known to specifically enhance X-
ray induced unstable aberrations, but not the stable ones (Natarajan et al. 1994, Bassi et al. 
2003).  Ara-C  is  one  of  a  group  of  chemotherapy  drugs  called  anti-metabolites.  Anti-
metabolites are similar to normal body molecules but they are slightly different in structure. 
Anti-metabolites often stop cells making and repairing DNA.  Cancer cells need to make and 
repair DNA to grow and multiply. This drug is used to treat acute leukemias, some head and 
neck cancers and non-Hodgkin’s lymphoma. 
Ara-C was purchased from Sigma (Italy)  and dissolved in RPMI-1640 medium at 
final concentration of 5 x 10-3 M and used at a concentration of 5 x 10–5  M  for treatment.
[R]-N-[tetradecylcarbamoyl]-aminocarnitine (STDS2323) (Paper IV) 
The generic  carnitine  palmitoyltransferase  (CPT) inhibitor  STDS2323,  a  substrate 
analog  mimicking  palmitoylcarnitine  and currently  in  clinical  trials  for  diabetes  mellitus 
treatment, was purchased from Sigma-Tau (Italy) and dissolved in RPMI-1640 medium at a 
final concentration of 15 μM and kept frozen at -20°C until use at appropriate concentrations 
for treatment.
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Bromodeoxyuridine (5-bromo-2-deoxyuridine, BrdUrd) (Paper I, III)
BrdUrd is a synthetic nucleoside which is an analogue of thymidine. It is commonly 
used in the detection of proliferating cells in living tissues. It can be incorporated into the 
newly  synthesized  DNA  of  replicating  cells  (during  the  S  phase  of  the  cell  cycle), 
substituting  during  DNA replication.  Scoring  the  metaphases,  the  BrdUrd-DNA labeling 
allows distinguishing the different cell division cycles. 
BrdUrd was purchased from Sigma (Italy) and dissolved in PBS at a concentration of 
10-3 M  and  kept  frozen  at  -20°C  until  use  at  appropriate  concentration  (6  μg/ml)  for 
treatment.
2’-deoxycitidine (dCTD) (Paper I)
dCTD is like cytidine (nucleoside) but with one oxigen atom removed. dCTD (Sigma, 
Italy)  was  dissolved  in  RPMI-1640  medium  as  a  10–2 M stock  solution  and  used  at  a 
concentration of 10–4 M for treatment. 
Phytohaemagglutinin (PHA) (Paper I, III, IV)
PHA is a lectin  found in plants.  Medically it  is  used as a mitogen to trigger cell 
division  in  T-lymphocytes.  It  is  known that  addition  of  mitogen  can  enhance  the  radio 
resistance of human lymphocytes (Meijer et al. 1999).
PHA was obtained from Murex Biotech Ltd (Dartford, UK), dissolved in PBS and 
used at a final concentration of 300 μg/ml.
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INDIVIDUAL PAPERS
Paper I
Since peripheral lymphocytes represent the most common target cells for biological 
dosimetric  studies,  it  was of interest  to understand to what  extent  the frequency of cells 
bearing  radiation-induced  unstable  chromosomal  aberrations,  depending  on  the  interval 
between exposure and sampling, is modulated by apoptosis. In particular, the present study 
was  designed to  determine  the  relationship  between the  frequencies  of  radiation-induced 
chromosomal alterations and the extent of apoptosis in G0 human lymphocytes.
The study has been conducted with human peripheral  blood lymphocytes  (HPBL) 
from  Swedish  and  Italian  healthy  donors.  HPBL  were  X-  or  gamma  irradiated,  in  the 
presence or absence of the repair inhibitor cytosine arabinoside (Ara-C), known to enhance 
the formation of unstable chromosome rearrangements. After irradiation, some lymphocytes 
were kept in G0 and analysed at various recovery times for cell viability and apoptosis. 
To  elucidate  further  the  relationship  between  DNA damage  and the  induction  of 
programmed cell death of X-irradiated G0 human lymphocytes, the status of the p53 protein 
was  investigated.  In  order  to  relate  radiation-induced  dicentrics  and  apoptosis,  the  G0 
lymphocytes were stimulated to proliferate immediately or 48 h after irradiation. Then the 
lymphocytes  were  analysed  for  the  frequencies  of  chromosomal  aberrations  at  various 
recovery times.
Our  results  showed  that  the  fraction  of  cells  bearing  dicentrics  was  reduced  in 
lymphocytes stimulated to grow 48 h post irradiation as compared to lymphocytes stimulated 
immediately after irradiation. The decrease in the frequency of dicentrics correlated with the 
increase in the number of apoptotic cells. The operative apoptotic pathway in irradiated G0 
lymphocytes was dependent on the expression of p53.
In conclusion, the data presented in this paper indicated that the radiation-induced 
apoptotic response of G0 lymphocytes is p53 dependent and increases with the time they are 
held in G0. When mitogen was added 48 h after irradiation, cells with dicentrics were either 
preferentially eliminated or did not enter mitosis. Thus the radiation-induced damage can be 
under  evaluated  depending on the time  between radiation  exposure and the  induction  of 
proliferation. These results may have relevance for biodosimetry studies or for evaluations of 
the efficacy of radiotherapy, which are based on the frequencies of chromosomal aberrations.
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Paper II
The  question  whether  there  is  a  direct  relationship  between  radiation-induced 
dicentric  chromosomes  and the  triggering  of  apoptosis  motivated  us  to  investigate  these 
effects in G0 human peripheral blood lymphocytes (PBLs). After 48 h of liquid holding in G0, 
i.e.,  in  normal-serum medium without  phytohaemagglutinin,  irradiated  lymphocytes  were 
divided by Ficoll gradient into a high-density fraction (the cell pellet at the bottom of the 
centrifugation tube) and a normal density fraction (the cells in the interphase layer). This is a 
simple  and  reproducible  technique  for  separating  apoptotic  (high-density)  and  normal 
(normal  density)  cells  on  the  basis  of  their  sedimentation  properties,  which  reflect  their 
different morphologies (Czene et al. 2002). All lymphocytes were analysed 0 and 48 h after 
irradiation for viability by trypan blue exclusion,  for apoptosis using JC-1 assay,  and for 
chromosome  damage  by  centromere-banding  (C-banding)  of  prematurely  condensed 
chromosomes. 
Our results showed that the majority of apoptotic cells, once prematurely condensed, 
contained dicentric chromosomes. These results demonstrated that in human lymphocytes, 
the  type  of  chromosome  damage  influence  the  induction  of  programmed  cell  death  and 
provide direct evidence that cells bearing dicentrics were eliminated by apoptosis. 
We concluded that apoptosis removes cells bearing dicentric chromosomes, under our 
experimental conditions. 
Paper III
Very  little  has  been  published  on  selection  and  validation  of  standard  operating 
procedures for quality of the samples and validity of the results and how they can affect the 
outcome  of  molecular  epidemiological  (Gunter  1997,  Landi  and  Caporaso  1997)  and 
biodosimetrical studies (IAEA 2001, Ramalho et al. 1995, Rao and Natarajan 2001). The loss 
of cellular viability that occurs during blood storage ex vivo is a major limitation and may 
have an impact on the reliable use of blood samples in biodosimetrical studies. 
As reported in the method devised by M.S. Sasaki  in  the Manual  of Cytogenetic 
Analysis for Radiation Dose Assessment, published by International Atomic Energy Agency 
(IAEA)  (2001),  the  problem  can  be  overcome  by  stimulating  the  lymphocytes  with 
phytohaemagglutinin (PHA) immediately after venipuncture and keeping them below 20°C 
so that the lymphocytes do not transform and progress through the cell cycle until the cells 
are warmed up to 37°C. 
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Since  the  role  of  radiation-induced  apoptosis  in  removing  human  lymphocytes 
bearing dicentrics has been directly demonstrated (Belloni et al. 2008), the aim of this study 
was to analyse the effect of storage conditions to retain viability of lymphocytes after 48-96 h 
up to 1 week of storage, depending on temperature, time of storage and presence of PHA.
Stimulated and unstimulated human whole blood samples were stored for 48-96 h up 
to 1 week at 4°C, 20°C and 37°C and were analysed for cell viability and apoptosis. After 96 
h and 1 week of storage unstimulated cultures were stimulated to proliferate. These cultures 
and samples  stimulated immediately before storing were incubated at  37°C for 56 h and 
analysed for mitotic index. 
The results of this study showed that lymphocytes undergo apoptosis during storage 
and this loss of viability is accelerated by increasing both temperature and storage time. In 
the  presence  of  PHA, incubation  at  both  4°C and 20°C for  48  h resulted  in  the  lowest 
percentage of apoptotic cells and after incubation at 4°C for 96 h the cultures grown for 56 h 
at 37°C revealed the highest percentage of mitotic index. 
In conclusion the data indicates that the storage conditions affected lymphocytes in 
terms of both cell viability and proliferation. Storage at 4°C for 96 h in presence of PHA was 
found  optimal.  The  use  of  proper  storage  conditions  may  have  a  strong  relevance  for 
preserving the cell viability especially studying the chemical or physical induced cytogenetic 
damage when the cell population is also affected by the apoptotic selective removal of cells 
bearing unstable type of aberrations (Schwartz and Jordan 2000, Bassi et al. 2003, Belloni et 
al. 2005). Therefore, in current methods in biodosimetrical and molecular epidemiological 
studies  the  storage  conditions  of  blood  specimens  have  to  be  considered  as  a  major 
requirement.
Paper IV
Among the emerging difficulties for the success of anticancer therapies the resistance 
to apoptosis induction represents the most common one. Radiation is an important tool in 
tumour therapy. The tumour suppressor protein p53 is known to be stabilized after ionizing 
radiation.  More than 50% of human tumours consist  of a mutated form of the p53 gene 
(Levine 1992). The protein has been called a “guardian of the genome” because its role to 
maintain genomic integrity by controlling cell cycle arrest or apoptosis. Since the onset of 
apoptotic  cell  death  is  frequently  p53-dependent,  tumours  that  lack  p53  function  often 
respond poorly to radiation and chemotherapy. This possibly defines pharmacological rescue 
of inactive p53 as an attractive therapeutic approach. 
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An alternative therapeutic strategy could account of the metabolic difference existing 
between  normal  and  tumour  cells.  During  the  progression  of  cancer,  mitochondria 
composition and function are affected acquiring features totally different from that of normal 
cells. In this work, the chemical compound STDS2323, an inhibitor of Carnitine Palmitoyl 
Transferase type 1 (CPT-1) enzyme involved in fatty acids transport into the mitochondria, 
was used to inactivate  the mitochondrial  function deeply compromised in cancer cells  in 
order to induce cell death.
Various  human  cell  lines  differing  in  their  characteristics  were  used.  Human 
peripheral blood lymphocytes were used as a normal control since these cells do not divide, 
they  normally  stay  in  the  G0 phase  of  the  cell  cycle,  and  also  are  prone  to  undergo  to 
apoptosis upon treatment with DNA damage inducing agents;  two human lymphoblastoid 
cell lines derived from the same donor, TK6 (p53 wild type) and WTK1 (p53 mutated) (Liber 
and Thilly 1982, Amundson et al. 1993); three human bladder cancer cell lines, the RT112, 
radioresistant  originally  established  from  a  transitional  cell  carcinoma  of  the  bladder 
characterized as homozygous for p53 mutations (Warenius et al. 2000), the MGH-U1 radio-
resistant  cell  line  from a  transitional  bladder  carcinoma  (Kato  et  al.  1997),  classified  as 
expressing wild type p53 (Warenius et al. 2000), and the U1-S40b, radiosensitive clone of 
MGH-U1 (Mc Millan and Holmes 1991). The aim of the present work was to study the effect 
of STDS2323 in terms of induction of cell death, cell survival, cell cycle progression and 
primary DNA damage among the different human cell types.
After  treatment  with  STDS2323 the  cell  viability  decreased  in  a  dose-  and  time- 
dependent fashion, depending on the various human cell types analysed.  Both the viability 
decrement and the apoptotic induction were more pronounced in cancer cell lines compared 
to the other cell types used. STDS2323 did not directly induce primary DNA damage in all 
cell  types  used. In  the  p53  wild  type  and  p53  mutated  lymphoblastoid  cell  lines  the 
progression of the cell cycle after treatment with STDS2323 was differently affected.
In conclusion, since STDS2323 induced apoptosis at the doses used for therapy only 
in the bladder cancer cell lines and did not in the human lymphocytes, it could be proposed as 
a potential anticancer drug for this type of tumour. It is remarkable that STDS2323 did not 
directly induce primary DNA damage in all human cell types employed in this study (G0 and 
G1 lymphocytes, TK6 and WTK1 lymphoblastoid cell lines, RT112, MGH-U1 and U1-S40b 
bladder  cancer  cell  lines).  The  metabolic  differences  existing  in  mitochondria  between 
normal and tumour cells may represent the target of the mechanism action of this chemical 
compound. The possible role of p53 in the induction of apoptosis and in the progression of 
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the cell  cycle  in the late-phase response after  treatment  with STDS2323 has  to  be more 
investigated.
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